[Comparison of the therapeutic effect of Atrovent inhalations with an oral antiasthmatic agent].
D000284:Administration, Oral; D001286:Atropine Derivatives; D001991:Bronchitis / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D004809:Ephedrine / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D011656:Pulmonary Emphysema / Q000188:drug therapy* / Q000503:physiopathology; D013806:Theophylline / Q000627:therapeutic use; D014797:Vital Capacity / Q000187:drug effects
D001286:Atropine Derivatives; D004338:Drug Combinations; D006634:Histamine H1 Antagonists; D013806:Theophylline; D004809:Ephedrine; D009241:Ipratropium
Vergleich des therapeutischen Effektes von Atrovent-Inhalationen mit der Wirkung eines oralen Asthmamittels